An association between Covid-19 vaccination and myocarditis has been previously reported.20 Although no cases of myocarditis were reported in the BNT162b2 (Pfizer–BioNTech),2 mRNA-1273 (Moderna),3 or ChAdOx1 nCoV-19 (AstraZeneca)4 phase 3 clinical trials, multiple cases of myocarditis after Covid-19 vaccination have recently been reported in the literature,21-25 and both the Israeli Ministry of Health26 and the CDC have investigated this association.27 The risk appears to be highest among young men.26,27 We found that the risk of myocarditis increased by a factor of three after vaccination, which translated to approximately 3 excess events per 100,000 persons; the 95% confidence interval indicated that values between 1 and 5 excess events per 100,000 persons were compatible with our data. Among the 21 persons with myocarditis in the vaccinated group, the median age was 25 years (interquartile range, 20 to 34), and 90.9% were male.
The effect of vaccination on the various potential adverse events included in this study is presented in Table 2. The risk was substantially higher on either the multiplicative (risk ratio) or additive (risk difference) scales in the vaccinated group than in the unvaccinated group for myocarditis (risk ratio, 3.24; 95% confidence interval [CI], 1.55 to 12.44; risk difference, 2.7 events per 100,000 persons; 95% CI, 1.0 to 4.6)
You forgot to quote the part with the stats after a Covid infection.
Table S6 shows the effect of SARS-CoV-2 infection on the incidence of various adverse events. Infection substantially increased the risk of many different adverse events, including myocarditis (risk ratio, 18.28; 95% CI, 3.95 to 25.12; risk difference, 11.0 events per 100,000 persons; 95% CI, 5.6 to 15.8), acute kidney injury (risk ratio, 14.83; 95% CI, 9.24 to 28.75; risk difference, 125.4 events per 100,000 persons; 95% CI, 107.0 to 142.6), pulmonary embolism (risk ratio, 12.14; 95% CI, 6.89 to 29.20; risk difference, 61.7 events per 100,000 persons; 95% CI, 48.5 to 75.4), ...
Or you can just take a look at this graph which compares it.
An association between Covid-19 vaccination and myocarditis has been previously reported.20 Although no cases of myocarditis were reported in the BNT162b2 (Pfizer–BioNTech),2 mRNA-1273 (Moderna),3 or ChAdOx1 nCoV-19 (AstraZeneca)4 phase 3 clinical trials, multiple cases of myocarditis after Covid-19 vaccination have recently been reported in the literature,21-25 and both the Israeli Ministry of Health26 and the CDC have investigated this association.27 The risk appears to be highest among young men.26,27 We found that the risk of myocarditis increased by a factor of three after vaccination, which translated to approximately 3 excess events per 100,000 persons; the 95% confidence interval indicated that values between 1 and 5 excess events per 100,000 persons were compatible with our data. Among the 21 persons with myocarditis in the vaccinated group, the median age was 25 years (interquartile range, 20 to 34), and 90.9% were male.
The effect of vaccination on the various potential adverse events included in this study is presented in Table 2. The risk was substantially higher on either the multiplicative (risk ratio) or additive (risk difference) scales in the vaccinated group than in the unvaccinated group for myocarditis (risk ratio, 3.24; 95% confidence interval [CI], 1.55 to 12.44; risk difference, 2.7 events per 100,000 persons; 95% CI, 1.0 to 4.6)
You forgot to quote the part with the stats after a Covid infection.
Or you can just take a look at this graph which compares it.
https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/0/nejm.ahead-of-print/nejmoa2110475/20210824/images/img_xlarge/nejmoa2110475_f4.jpeg
Ah thanks! I was wondering what the hell I was missing.
But 11 per 100,000 isn't very high.
And 3 is even lower and yet people freak out about it.